Sonazoid Enhanced LivEr Cancer Trial for Early Detectio
Not Applicable
- Conditions
- Hepatitis B virus or Hepatitis C virus related liver cirrhosis
- Registration Number
- JPRN-UMIN000001612
- Lead Sponsor
- Japan Liver Oncology Group (JLOG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 656
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of hypersensitivity to egg yolk 2) Pregnant or lactating women and women who may be pregnant 3) Severe liver dysfunction(AST, ALT,or BIL level >10ULN 4) Associated with HCC 5) Paients receiving interferon 6) Age under 20 7) Judged by investigator not to be appropriate for inclusion in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Size of HCC which is detected first
- Secondary Outcome Measures
Name Time Method 1) Time to detection of HCC 2) Number of HCC which is detected first 3) Stage of HCC which is detected first 4) The ability of definitive diagnosis of HCC 5) Sensitivity, Specificity and accuracy of the diagnosis of HCC 6) The improvement of prognosis of patients who are diagnosed in this study 7) The accumulated rate of detection of HCC